Health Screening and Referral for Premature Birth
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist families with preterm infants by connecting them to social resources such as housing or job support. Preterm babies often encounter health challenges, and enhancing their social environment can significantly impact their well-being. The trial will evaluate whether offering these services in the NICU (Neonatal Intensive Care Unit) setting, through the implementation of social determinants of health screening and referral, can improve outcomes for these vulnerable babies and their families. It is suitable for mothers who will care for their infants at home in the U.S. for at least a year after discharge and can speak and read English or Spanish. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could greatly enhance support systems for families with preterm infants.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
What prior data suggests that this protocol is safe for preterm infants and their families?
Research has shown that addressing social factors can improve the health of preterm babies and their families. These factors include stable housing, secure employment, and access to healthcare. This trial does not involve medication or medical procedures. Instead, it focuses on assessing family needs and connecting them to helpful resources.
As the trial involves screening and referrals, it is safe. There are no medical risks because it involves support services, not medical treatments. The aim is to provide families with necessary resources, which is not expected to cause harm. In fact, it seeks to enhance the health of both babies and their families by addressing unmet social needs.12345Why are researchers excited about this trial?
Unlike traditional treatments for preventing premature birth that often focus solely on medical interventions, the social determinants of health screening and referral is unique because it targets the underlying social factors that can contribute to preterm birth, such as housing instability, food insecurity, and access to healthcare. Researchers are excited about this approach because it aims to address root causes and could lead to more sustainable, long-term benefits for maternal and fetal health. By implementing a comprehensive screening and referral system, this method has the potential to personalize care and improve outcomes by connecting individuals to necessary social resources and support networks.
What evidence suggests that this screening and referral method is effective for addressing social needs in preterm infants?
Research shows that improving factors like housing and access to resources greatly benefits infant health. Studies have found that issues such as lack of prenatal care or unstable housing lead to poorer health for babies. By identifying these issues and connecting families to resources, these problems can be addressed early. Previous efforts elsewhere have shown that providing families with necessary support improves health outcomes. This trial will implement social determinants of health screening and referral in neonatal intensive care units (NICUs) to evaluate its effectiveness, aiming for similar positive results.12356
Who Is on the Research Team?
Margaret Parker, MD, MPH
Principal Investigator
University of Massachusetts Chan Medical School
Mari-Lynn Drainoni, PhD, MEd
Principal Investigator
Boston University Chobanian and Avedisian School of Medicine
Arvin Garg, MD, MPH
Principal Investigator
University of Massachusetts Chan Medical School
Are You a Good Fit for This Trial?
This trial is for families with preterm infants who may be facing social challenges like not having a stable place to live or job security. It aims to help those in the NICU by identifying and addressing these issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Usual Care Phase
Sites participate in the usual care phase before the intervention begins
Experimental Phase
Implementation of SDOH screening and referral models in NICUs
Sustainment Phase
Continued screening and referral after active intervention
Follow-up
Participants are monitored for outcomes such as maternal mental health and infant development
What Are the Treatments Tested in This Trial?
Interventions
- Implementation of social determinants of health screening and referral
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Massachusetts, Worcester
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator